Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
Current Opinion in Lipidology|February 6, 2020
Are dietary fish oil supplements appropriate for dyslipidemia management? A review of the evidenceSamuel C R Sherratt, Michael Lero, R Preston MasonBiochimica Et Biophysica Acta|March 22, 2003
Direct evidence for cholesterol crystalline domains in biological membranes: role in human pathobiologyR Preston Mason, Thomas N Tulenko, Robert F JacobCirculation|June 3, 2004
Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stressR Preston Mason, Mary F Walter, Robert F JacobCurrent Diabetes Reports|October 23, 2020
The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk ReductionXiaowen Wang, Subodh Verma, R Preston Mason, et al.Biochimica Et Biophysica Acta. Biomembranes|March 6, 2020
Eicosapentaenoic acid (EPA) has optimal chain length and degree of unsaturation to inhibit oxidation of small dense LDL and membrane cholesterol domains as compared to related fatty acids in vitroSamuel C R Sherratt, Rebecca A Juliano, R Preston MasonJournal of Cardiovascular Pharmacology|March 6, 2016
Eicosapentaenoic Acid Inhibits Oxidation of ApoB-containing Lipoprotein Particles of Different Size In Vitro When Administered Alone or in Combination With Atorvastatin Active Metabolite Compared With Other Triglyceride-lowering AgentsR Preston Mason, Samuel C R Sherratt, Robert F JacobBest Practice & Research. Clinical Endocrinology & Metabolism|June 23, 2022
Omega-3-fatty acids: Do they prevent cardiovascular disease?R Preston Mason, Samuel C R Sherratt, Robert H EckelBiochimica Et Biophysica Acta. Biomembranes|December 25, 2018
Rosmarinic acid and its esters inhibit membrane cholesterol domain formation through an antioxidant mechanism based, in nonlinear fashion, on alkyl chain lengthSamuel C R Sherratt, Pierre Villeneuve, Erwann Durand, et al.Postgraduate Medicine|October 5, 2017
Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?John R Nelson, Wayne S True, Viet Le, et al.European Journal of Preventive Cardiology|January 3, 2024
Omega-3 fatty acids for cardiovascular event loweringGurleen Kaur, R Preston Mason, Ph Gabriel Steg, et al.Pageof 10